Coreg (carvedilol) is a small molecule pharmaceutical. Carvedilol was first approved as Coreg on 1995-09-14. It is used to treat angina pectoris, heart failure, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-2 adrenergic receptor and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor and ryanodine receptor 2.
|Indication||angina pectoris, heart failure, hypertension, myocardial infarction|
|Drug Class||Vasodilators (undefined group)|